New York State Department of Financial Services reapproved a previous proposal for China Oceanwide Holdings Group Co. Ltd. (Oceanwide)’s acquisition of Genworth Life Insurance Company of New York (GLICNY). Genworth Financial, the parent company of Genworth Life Insurance, reported the news with Oceanwide on March 24. The New York State Department of Financial Services had […]
On March 23, Fortress Biotech (FBIOP) reported that its Board of Directors authorized a share repurchase program. Under the terms of the agreement, Fortress Biotech can repurchase up to $5 million of its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock. Fortress Biotech appointed ThinkEquity to purchase the stock on behalf of the company in […]
On March 16, Correvio Pharma Corp. (CORV) announced that the company signed an acquisition agreement with Advanz Pharma Corp. Limited (ADVZ). Advanz Pharma will pay approximately $76 million for all outstanding Correvio shares and will execute the acquisition through its wholly-owned subsidiary, Mercury Pharma Group Limited. Correvio is a specialty pharmaceutical company focusing on commercializing […]
On March 12, Heritage Financial Corporation (HFWA) announced that the company’s Board of Directors authorized a new share repurchase program. This new stock repurchase program follows one authorized in 2014 in which the company repurchased 1,512,600 shares of common stock. The new program allows Heritage Financial to repurchase approximately 1.8 million shares, or up to […]
The February 2020 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide
On March 2, Gilead Sciences Inc. (GILD.O) announced that it will acquire Forty Seven Inc. (FTSV.O) for $4.9 billion in cash. Gilead Sciences was particularly interested in adding an experimental treatment targeting blood cancer to its portfolio of oncology drugs. Forty Seven’s leading drug, magrolimab, switches off the CD47 signal that allows tumor cells to […]
On March 3, Thermo Fisher Scientific Inc. (TMO) and Qiagen N.V. (QGEN) announced that the Board of Directors from both companies approved Thermo Fisher’s proposal to acquire Qiagen. Under the terms of the agreement, Thermo Fisher will pay €39 per share in cash for Qiagen, which values the company at around $11.5 billion. Qiagen is […]
GAIN Capital Holdings, Inc. (GAIN) announced on February 27 that the company entered into an acquisition agreement with INTL FCStone, Inc. Under the terms of the agreement, INTL FCStone will purchase GAIN Capital Holdings in an all-cash transcaction. Stockholders will receive $6 per share for a total of approximately $236 in equity value. Sonal […]
On February 26, InflaRx, N.V. (IFRX) announced positive initial data from the first 5 patients enrolled in its Phase IIa open label clinical trial for IFX-1. Two out of the five patients achieved complete remission of Pyoderma Gangraenosum (PG), a rare and debilitating autoinflammatory skin disease. Although the exact prevalence of PG is unknown, current […]
On February 10, Brighthouse Financial Inc., (BHF) reported that the company’s Board of Directors authorized a $500 million share repurchase program. This authorization is in addition to the $600 million in share repurchase authorization outstanding from August 2018 and May 2019. Brighthouse Financial has already repurchased approximately $570 million in common stock. Sonal alerted […]
The January 2020 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide
Let us send you a summary of the signals Sonal generates EVERY WEEK… and you can decide if you’re missing anything.